Nurix Therapeutics Inc. (NRIX) Social Stream
NURIX THERAPEUTICS INC (NRIX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NRIX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 8 | $64 | $42 | $50.285 | $9.75 | 415.74% |
| 2021-12-29 | 8 | $64 | $42 | $51.75 | $9.75 | 430.77% |
| 2022-01-28 | 8 | $64 | $42 | $52.857 | $9.75 | 442.12% |
| 2022-01-31 | 8 | $64 | $42 | $51.571 | $9.75 | 428.93% |
| 2022-02-08 | 8 | $62 | $37 | $47.714 | $9.75 | 389.37% |
| 2022-04-07 | 9 | $62 | $28 | $45.25 | $9.75 | 364.1% |
| 2022-04-13 | 9 | $62 | $28 | $44.875 | $9.75 | 360.26% |
| 2022-04-28 | 6 | $60 | $28 | $45 | $9.75 | 361.54% |
| 2022-05-22 | 7 | $60 | $25 | $44.5 | $9.75 | 356.41% |
| 2022-05-31 | 7 | $60 | $25 | $40.714 | $9.75 | 317.58% |
| 2022-10-07 | 8 | $53 | $25 | $36 | $9.75 | 269.23% |
| 2022-10-11 | 9 | $53 | $11 | $33.222 | $9.75 | 240.74% |
| 2023-02-07 | 9 | $53 | $11 | $32.222 | $9.75 | 230.48% |
| 2023-02-12 | 10 | $53 | $11 | $32.222 | $9.75 | 230.48% |
| 2023-02-14 | 10 | $53 | $11 | $31.3 | $9.75 | 221.03% |
| 2023-02-24 | 11 | $53 | $11 | $31.2 | $9.75 | 220% |
| 2023-02-28 | 11 | $53 | $11 | $30.636 | $9.75 | 214.22% |
| 2023-03-21 | 12 | $53 | $11 | $29.75 | $9.75 | 205.13% |
| 2023-04-14 | 12 | $53 | $11 | $30.181 | $9.75 | 209.55% |
| 2023-04-27 | 12 | $53 | $11 | $29.909 | $9.75 | 206.76% |
| 2023-06-26 | 11 | $53 | $11 | $29.909 | $9.75 | 206.76% |
| 2023-07-13 | 8 | $53 | $11 | $29.7 | $9.75 | 204.62% |
| 2023-07-16 | 10 | $53 | $12 | $29.8 | $9.75 | 205.64% |
| 2023-09-07 | 10 | $36 | $12 | $27.8 | $9.75 | 185.13% |
| 2023-10-16 | 10 | $36 | $12 | $28.1 | $9.75 | 188.21% |
| 2023-11-10 | 10 | $36 | $9 | $27.2 | $9.75 | 178.97% |
| 2023-12-18 | 12 | $36 | $9 | $26.583 | $9.75 | 172.65% |
The Trend in the Analyst Price Target
NRIX's average price target has moved down $17.92 over the prior 20 months.
NRIX reports an average of 261.2% for its upside potential over the past 45 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-12 | 10 | 53 | 11 | 32.222 | 11.65 | 176.58% |
| 2023-02-14 | 10 | 53 | 11 | 31.300 | 10.83 | 189.01% |
| 2023-07-16 | 10 | 53 | 12 | 29.800 | 9.76 | 205.33% |
| 2023-11-10 | 10 | 36 | 9 | 27.200 | 5.27 | 416.13% |
| 2023-11-10 | 11 | 36 | 9 | 26.583 | 5.27 | 404.42% |
NRIX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 9 | 2 | 1 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
NRIX's average broker recommendation rating improved by 0.07 over the prior 26 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, NURIX THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 3496.72% of them.
- To contextualize these metrics, consider that out of all US stocks, NURIX THERAPEUTICS INC's variance in analysts' estimates is lower than -3130.24% of them.
- NURIX THERAPEUTICS INC's number of analysts covering the stock is greater than 3595.29% of stocks in the small market cap category.
- In terms of how NURIX THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 3102.32% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NURIX THERAPEUTICS INC are PHAR, TRDA, and TSVT.
View All Top Stocks by Price Target
Make investment decisions regarding NRIX using the data that counts. Try POWR Ratings for free.